Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-04-05
2011-04-05
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S157000, C514S313000
Reexamination Certificate
active
07919625
ABSTRACT:
Compounds of the formula:wherein:n is an integer from 1-3;X is N, CH, provided that when X is N, n is 2 or 3;R is alkyl of 1 to 3 carbon atoms;R1is 2,4-diCl, 5-OMe; 2,4-diCl; 3,4,5-tri-OMe; 2-Cl, 5-OMe; 2-Me, 5-OMe; 2,4-di-Me; 2,4-diMe-5-OMe, 2,4-diCl, 5-OEt;R2is alkyl of 1 to 2 carbon atoms, and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 6002008 (1999-12-01), Wissner et al.
patent: 6780996 (2004-08-01), Boschelli et al.
patent: 7417148 (2008-08-01), Boschelli et al.
patent: WO 03/093241 (2003-11-01), None
patent: WO 2004/075898 (2004-09-01), None
Boschelli, J Med Chem, vol. 44, pp. 822-833, 2001.
Boschelli, J Med Chem, vol. 44, pp. 3965-3977, 2001.
Boschelli, D.H.; et al.; J. Med. Chem. 44:3965-3911 (2001).
Boschelli, D.H.; et al.; J. Med. Chem. 47:1599-1601 (2004).
Boschelli, D.H., et al.; J. Med. Chem. 44:822-833 (2001).
Boschelli, D.H., et al.; Bioorganic & Medicinal Chemistry Letters 13:3797-3800 (2003).
Golas, J.M.; et al.; Cancer Research 63:375-381 (Jan. 15, 2003).
Ye, F.; 221stNational Meeting of the American Chemical Society, San Diego (Apr. 2001).
Registry compound No. 220127-57-1, Mar. 3, 1999.
Huy, et al., “Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia”, Nature Genetics, vol. 36, (2004) pp. 453-461.
Berger, D., et al.; Substituted 4-Anillno-7-phenyl-3-quinolinecarbonitriles as Src Kinase inhibitors; Bioorg. Med. Chem. Lett 12:2989-2992 (2002).
Arndt Kim T.
Boschelli Frank
Golas Jennifer M.
Rubin David
Seaman D. Margaret
Tidwell Jeffrey H.
Wyeth LLC
LandOfFree
4-anilino-3-quinolinecarbonitriles for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-anilino-3-quinolinecarbonitriles for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-anilino-3-quinolinecarbonitriles for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2680706